Retention Rates of TNF Inhibitors and Abatacept Used as a First Biologic DMARD in the Treatment of Rheumatoid Arthritis: 8 Years of Experience from the Rhumadata (R) Registry

导出原文传递

翻译打印收藏纠错

作者： Choquette, Denis ^[1] ; Bessette, Louis ^[2] ; Alemao, Evo ^[3] ; Haraoui, Boulos ^[4] ; Massicotte, Frederic ^[5] ; Mtibaa, Mondher ^[6] ; Muratti, Eleonora ^[7] ; Pelletier, Jean-Pierre ^[8] ; Postema, Roelien ; Raynauld, Jean-Pierre ; Remillard, Marie-Anais ; Sauvageau, Diane ; Turcotte, Angele ; Villeneuve, Edith ; Coupal, Louis

作者单位： Laval Univ, Quebec City, PQ, Canada ^[1] Bristol Myers Squibb, Princeton, NJ USA ^[2] Ctr Hosp Univ Montreal, Dept Med, Montreal, PQ, Canada ^[3] Bristol Myers Squibb, Montreal, PQ, Canada ^[4] Inst Rhumatol Montreal, Montreal, PQ, Canada ^[5] Bristol Myers Squibb, Uxbridge, Middx, England ^[6] Bristol Myers Squibb Canada, St Laurent, PQ, Canada ^[7] Ctr Osteoporose & Rhumatol Quebec, Quebec City, PQ, Canada ^[8]

发布时间 2020-08-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

The Journal of rheumatology

2018年45卷7期

1053-1053页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Retention Rates of TNF Inhibitors and Abatacept Used as a First Biologic DMARD in the Treatment of Rheumatoid Arthritis: 8 Years of Experience from the Rhumadata (R) Registry

The Journal of rheumatology

相似文献

The Journal of rheumatology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Retention Rates of TNF Inhibitors and Abatacept Used as a First Biologic DMARD in the Treatment of Rheumatoid Arthritis: 8 Years of Experience from the Rhumadata (R) Registry

The Journal of rheumatology

相似文献

The Journal of rheumatology

相关期刊

检索历史清除